NCT00298779View on ClinicalTrials.gov

Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
TumorsNon-Hodgkins's Lymphoma
Interventions
DRUG

omeprazole and bortezomib

Trial Locations (1)

75246

Mary Crowley Medical Research Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Millennium Pharmaceuticals, Inc.

INDUSTRY

NCT00298779 - Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma. | Biotech Hunter | Biotech Hunter